Share-based Payment Arrangement, Expense of PRESSURE BIOSCIENCES INC from 30 Jun 2011 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PRESSURE BIOSCIENCES INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2011 to 30 Jun 2024.
  • PRESSURE BIOSCIENCES INC Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $2,406,323.
  • PRESSURE BIOSCIENCES INC annual Share-based Payment Arrangement, Expense for 2023 was $2,636,443, a 1126% increase from 2022.
  • PRESSURE BIOSCIENCES INC annual Share-based Payment Arrangement, Expense for 2022 was $215,098.
  • PRESSURE BIOSCIENCES INC annual Share-based Payment Arrangement, Expense for 2014 was $101,125, a 26% decline from 2013.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PRESSURE BIOSCIENCES INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $2,406,323 01 Apr 2024 30 Jun 2024 10-Q 07 Feb 2025 2024 Q2
Q1 2024 $240,292 -$1,189,952 -83% 01 Jan 2024 31 Mar 2024 10-Q 06 Sep 2024 2024 Q1
Q1 2023 $1,430,244 01 Jan 2023 31 Mar 2023 10-Q 06 Sep 2024 2024 Q1
Q3 2016 $90,500 +$15,636 +21% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $90,849 +$35,233 +63% 01 Apr 2016 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 $101,462 +$46,572 +85% 01 Jan 2016 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q3 2015 $239,724 $74,864 +$68,477 +1072% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $171,247 $55,616 +$34,128 +159% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $137,119 $54,890 +$35,994 +190% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q4 2014 $101,125 $54,354 +$37,806 +228% 01 Oct 2014 31 Dec 2014 10-K 31 Mar 2015 2014 FY
Q3 2014 $63,319 $6,387 -$85,844 -93% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $149,163 $21,488 +$12,511 +139% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 $136,652 $18,896 -$144 -0.76% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q4 2013 $136,796 $16,548 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 $92,231 -$4,495 -4.6% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $8,977 -$2,245 -20% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 $19,040 +$10,172 +115% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q3 2012 $96,726 +$64,206 +197% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013 2013 Q3
Q2 2012 $11,222 -$980 -8% 01 Apr 2012 30 Jun 2012 10-Q 15 Aug 2013 2013 Q2
Q1 2012 $8,868 01 Jan 2012 31 Mar 2012 10-Q 20 May 2013 2013 Q1
Q3 2011 $32,520 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q3
Q2 2011 $12,202 01 Apr 2011 30 Jun 2011 10-Q/A 10 Sep 2012 2012 Q2

PRESSURE BIOSCIENCES INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $2,636,443 +$2,421,345 +1126% 01 Jan 2023 31 Dec 2023 10-K 07 Jun 2024 2023 FY
2022 $215,098 01 Jan 2022 31 Dec 2022 10-K 07 Jun 2024 2023 FY
2014 $101,125 -$35,671 -26% 01 Jan 2014 31 Dec 2014 10-K 31 Mar 2015 2014 FY
2013 $136,796 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.